Abstract
Systemic Sclerosis (SSc) is a multisystem disease that affects the skin and internal organs (i.e., gastrointestinal tract, lung, heart, kidney and peripheral nervous system). In the early phase, lung involvement is characterized by interstitial inflammatory alterations that are detected by bronchoalveolar lavage analysis and high resolution computed tomography (ground glass). As the disease progresses, fibrotic changes become evident and the diffusing capacity for carbon monoxide (DLCO) is impaired. Cardiac involvement in SSc can be manifested as myocardial disease, pericardial disease, conduction system disease, or arrhytmias. Cardiac involvement is a poor prognostic factor, but the diagnosis may be late or missing because of the frequent discrepancy between clinical manifestations and the real cardiac involvement. For this reason, resort to all the available diagnostic procedures is recomended to achieve an early diagnosis. The motility disorders are a major feature of gastrointestinal involvement in SSc, striking any part of this system (especially esophagus and anorectal region). Kidney involvement and scleroderma renal crisis are now considered rare because of the introduction of ACE inhibitors. Some patients may develop myositis or erosive arthropathy that complicate enormously the joint retraction induced by skin fibrosis. The peripheral nervous system (PNS) is also targeted by SSc: a distal mononeuropathy of the median nerve is a frequent and early feature; autonomic nerve dysfunction (parasympathetic impairment and marked sympathetic overactivity) seems to be a fundamental etiologic factor linked to the development of microvascular, cardiac and gastrointestinal alterations.
The whole approach to the SSc patient is very complex and must consider, at the same time, many organs and systems. Thus, a global vision of SSc patient is needed in order to assure an early diagnosis of specific organ involvement as well as early treatment.
Systemic Sclerosis (SSc) is a multisystem disease, that affects the skin, the gastrointestinal tract, the lung, the heart and the kidney. The extent and severity of internal organ involvement are the more important factors influencing the disease outcome and prognosis in SSc. In recent years, it has become evident that early diagnosis and accurate staging of visceral involvement are fundamental for appropriate management and therapeutic approach to the disease.
Diagnostic procedures for specific organ and system involvement are now more sensitive because of the continuous technological improvement and, mostly, because they take advantage of the studies carried out in other diseases by other medical branches. This review will consider briefly the most frequent and important organ involvement in SSc.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Pignone A, Matucci Cerinic M, Lombardi A, Fedi R, Fargnoli R, De Dominicis R, Cagnoni M: High Resolution computed in Systemic Sclerosis. Real diagnostic utilities in the assessment of pulmonary involvement and comparison with other modalities of lung investigation. Clin Rheumatol 11: 465–4-72. 1992
Silver RM, Scott Miller K: Lung involvement in Systemic Sclerosis. Rheum Dis Clin N Am 16: 199–216. 1990
Wells AU, Hansell DM, Rubens MB, Cullinan P, Black CM, du Bois RM: The Predictive value of Appearances on Thin-section Computed Tomography in Fibrosing Alveolitis. Am Rev Respir Dis 148: 1076–1082. 1993
Wells AU, Hansell DM, Rubens MB, King AD, Cramer D, Black CM, du Bois RM: Fibrosing alveolitis in Systemic Sclerosis: indices of lung function in relation to extent of disease on computed tomography. Arthitis Rheum 40: 1229–1236. 1997
Dévényi K, Czirjak L: High Resolution Computed Tomography for the Evaluation of Lung Involvement in 101 Patients with Scleroderma. Clin Rheumat 14: 633–640. 1995
Wells AU, Hansell DM, Corrin B, Harrison NK, Goldstraw P, Black CM, du Bois RM: High Resolution Computed Tomography as a predictor of lung Histology in Systemic Sclerosis. Thorax 47: 738–742. 1992
Warrick JH, Meenakshi Bhalla, Schabel SI, Silver RM: High Resolution Computed Tomography in early scleroderma lung disease. J Rheumatol 18: 1520–1528. 1991
Agusti C, Xaubet A, Luburich P, Ayuso MC, Roca J, Rodriguez-Roisin R: Computed tomography-guided bronchoalveolar lacage in idiopathic pulmonary fibrosis. Thorax 51: 841–845. 1996
Silver RM: Interstitial Lung Disease of Systemic Sclerosis. Intern Rev Immunol 12: 281–291. 1995
Silver RM: Clinical Problems: The Lung. Rheum Dis Clin N Am 22: 825–840. 1996
Bolster MB, Ludwicka A, Sutherland SE, Strange C, Silver RM: Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis. Arthritis Rheum 40: 743–751. 1997
Wells AU, Hansell DM, Rubens MB, Cullinan P, Haslam PL, Black CM, du Bois RM: Fibrosing Alveolitis in Systemic Sclerosis; Bronchoalveolar Lavage Findings in Relation to Computed Tomographic Appearance. Am J Respir Crit Care Med 150: 462–468. 1994
Behr J, Volgelmeier C, Beinert T, Meurer M, Krombach F, Konig G, Fruhmann G: Bronchoalveolar Lavage For Evaluation and Management of Scleroderma Disease of the Lung. Am J Respir Crit Care Med 154: 400–406. 1996
Clements PL, Furst DE, Cabeen W, Tashkin D, Paulus HE, Roberts N: The relationship of arrhythmias and conduction disturbances to other manifestations of cardiopulmonary disease in progressive systemic sclerosis. Am J Med 71: 38–46. 1981
Deswal A, Follansbee WP: Cardiac involvement in scleroderma. Rheum Dis Clin N Am 22: 841–860. 1996
Medsger TA Jr, Masi AT, Rodnan JP, et al: Survival with systemic sclerosis (scleroderma): A life-table analysis of clinical and demographic factors in 309 patients. Ann Int Med 75: 369–376. 1971
Kahan A, Devaux J, Amor B, et al: The effect of captopril on thallium 201 myocardial perfusion in systemic sclerosis. Clin Pharmacol Ther 47: 483–489. 1990
Steen VD, Follansbee WP, Conte CG, Medsger TA Jr: Thallium perfusion defects predict subsequent cardiac dysfunction in patients with systemic sclerosis. Arthritis Rheum 39: 677–681. 1996
Schwartz PJ, La Rovere MT, Vanoli E: Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation. 85(Suppl 1): 177–191. 1992
Ferri C, Emdin M, Giuggioli D, et al: Autonomic dysfunction in Systemic Sclerosis: time and frequency domain 24 hour heart rate variability analysis. Br J Rheum 36: 669–676. 1997
Pignone A, Matucci-Cerinic M, Becucci A et al: Patterns of ventricular late potentials in systemic sclerosis: a noninvasive method in the study of cardiac involvement. Ann Ital Med Int 9: 141–145. 1994
Rosada M, Cozzi F, Bullo A, et al: Prevalence of ventricular late potentials in systemic sclerosis and analysis of clinical and 24 hour elettrocardigraphy associations. Reumatismo 49 (suppl. 3): 221. 1997
Morelli S, Sgreccia A, De Marzio, et al: Noninvasive assessment of myocardial involvement in patients with systemic sclerosis: role of signal averaged electrocardiography. J Rheumatol 24: 2358–2363. 1997
Kahan IJ, Menkes C: Gastrointestinal involvement in systemic sclerosis. Clin Dermatol 12: 259–265. 1994
Young MA, Rose S, Reynolds JC: Gastrointestinal manifestations of scleroderma. Rheum Dis Clin N Am 22: 797–823. 1996
Greydanus MP, Camilleri M: Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis. Gastroenterology 96: 110–115. 1989
Akesson A, Ekman R, Prytz H, Sundler F: tissue concentrations of gastrointestinal regulatory peptides in the duodenal mucosa in systemic sclerosis. Clin Exp Rheumatol 16: 141–148. 1998
Rohrmann CA Jr, Ricci MT, Krihnamurthy S, et al: Radiologic and histologic differentiation of neuromuscolar disorders of the gastrointestinal tract. Visceral myopathies, visceral neuropathies, and progressive systemic sclerosis. AJR 143: 933–941. 1981
Bassotti G, Battaglia E, Debernardi V, et al: Esophageal dysfunction in scleroderma: relationship with disease subsets. Arthritis Rheum 40: 2252–2259. 1997
Schima W, Stacher G, Pokieser P, et al: Esophageal motor disorders: videofluoroscopic and manometric avaluation-prospective study in 88 symptomatic patients. Radiology 185: 487–491. 1992
Miller LS, Liu JB, Klenn PJ, et al: Endoluminal ultrasonography of the distal esophagus in systemic sclerosis. Gastroenterology. 105: 31–39. 1993
Manolios N, Eliades C, Duncombe V, Spencer D: Scleroderma and watermelon stomach. J Rheumatol 23: 776–778. 1996
Corazza GR, Di Sabatino A, Brusco G, Di Stefano M: Malabsorption in systemic sclerosis. Clin Exp Rheumatol 16 (suppl), in press. 1998
Sjögren RW: Gastrointestinal motility disorders in scleroderma. Arthritis Rheum 9: 1265–1282. 1994
Strocchi A, Levitt MD: Breath hydrogen measurement of small bowel transit time. In Schuster MM (ed): Atlas of gastrointestinal motility in health and disease. Baltimore, Williams and Wilkins, 1993.
Jaffin BW, Chang P, Spiera H: Fecal incontinence in scleroderma. Clinical features, anorectal manometric findings, and their therapeutic implications. J Clin Gastroenterol 25: 513–517. 1997
Traub YN, Shapiro AP, Rodnan GP, et al: Hypertention and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases. Medicine 62: 335–352. 1983
Chapman PJ, Pascoe MD, Van Zyl-Smit R: Successful use of captopril in the treatment of “scleroderma renal crisis”. Clin Nephrol 26: 106–108. 1986
Steen VD, Medsger TA Jr, Osial TA Jr, at al: Factors predicting development of renal involvement in progressive systemic sclerosis. Am J Med 76: 779–786. 1984
Steen VD: Scleroderma renal crisis. Rheum Dis Clin N Am 22: 861–878. 1996
Black CM, Stephens C: Systemic sclerosis (Scleroderma) and related disorders. In Oxford Textbook of Rheumatology, (eds. PJ Maddison, DA Isenberg, P Woo, DN Glass), pp. 771–794. Oxford University Press. 1993
Trostle DC, Bedetti CD, Steen VD, et al: Renal vascular histology and morphometry in systemic sclerosis subset: A case-control autopsy study. Arthritis Rheum 3: 393–400. 1988
Generini S, Castellani S, Pellegri M, Matteini M, Pignone A, Matucci Cerinic M: Angiotensin converting enzyme and altered renal autoregulation in Ssc. Arthritis Rheum 40 (suppl): S296. 1997
Livi R, Teghini L, Biagini M, Scarpelli PT, Cagnoni M: Renal functional reserve in systemic sclerosis. Clin Exp Rheumatol 16 (suppl), in press. 1998
Russell ML: Muscle and nerve in systemic sclerosis (scleroderma). In Systemic sclerosis: scleroderma, 1988 eds. C. M Black and MIV Jayson. Wiley, Chirchester.
Follansbee WP, Zerbe TR, Medsger TA: Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): A high risk association Am Heart J 125: 194–203. 1993
Olsen NJ, King LE, Park JH: Muscle abnormalities in scleroderma. Rheum Dis Clin N Am 22: 783–796. 1996
Hietaharju A, Jaaskelainen S, Kalimo H, Hietarinta M: Peripheral neuromuscular manifestations in systemic sclerosis (scleroderma). Muscle Nerve Nov; 16(11): 1204–1212. 1993
Lori S, Matucci Cerinic M, Casale R, Generini S, Lombardi A, Pignone A, Scaletti C, Gangemi PF, Cagnoni M: Peripheral nervous system involvement in systemic sclerosis: the median nerve as a target structure. Clin Exp Rheumatol 14: 601–605. 1996
Matucci Cerinic M, Generini S, Pignone A, Casale R: The nervous system in systemic sclerosis (scleroderma). Rheum Dis Clin N Am 22: 879–892. 1996
Comi G, Comola M, Nemni R, et al: Study of a case of neuropathy associated with progressive systemic sclerosis. Acta Neurol 4: 258–261. 1982
Klimiuk PS, Taylor L, Baker RD, et al: Autonomic neuropathy in systemic sclerosis. Ann Rheum Dis 47: 542–545. 1988
Sonnex C, Paice E, White AG: Autonomic neuropathy in systemic sclerosis: A case report and evaluation of six patients. Ann Rheum Dis 45: 957–960. 1986
Dessein PHMC, Joffe BL, Metz RM, et al: Autonomic dysfunction in systemic sclerosis: Sympathetic overactivity and instability. Am J Med 93: 143–150. 1992
Pochas E, Andriotakis C, Kaklamanis P, Antonopoulos M: Joint involvement in systemic lupus erythematosus and in scleroderma (systemic sclerosis). Acta Rheum Scand 13: 137–149. 1967
Schumacher HR Jr: Joint and periarticular involvement in systemic sclerosis. Clin Dermatol 12: 277–282. 1994
Ward M, Cure J, Schabel S, Schabel S, Smith EA, Schumacher HR Jr, Silver RM: Symptomatic spinal calcinosis in systemic sclerosis (scleroderma). Arthritis Rheum 40: 1892–1895. 1997
Steen VD, Medsger TA Jr: The palpable tendon friction rub: an important physical examination finding in patients with systemic sclerosis. Arthritis Rheum 40: 1146–1151. 1997
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Generini, S., Fiori, G., Pignone, A.M., Cerinic, M.M., Cagnoni, M. (1999). Systemic Sclerosis. In: Mallia, C., Uitto, J. (eds) Rheumaderm. Advances in Experimental Medicine and Biology, vol 455. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4857-7_11
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4857-7_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7203-5
Online ISBN: 978-1-4615-4857-7
eBook Packages: Springer Book Archive